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It has previously been reported (Emerson and Cushing, 1946; Emerson,
1947) that the so-called sulfonamide-requiring mutant strain of Neurospora
(strain E-15172, hereafter designated by the symbol "sfo") does not grow on
minimal medium at 35 C, that the addition of sulfanilamide (SA) permits
maximum growth at that temperature and augments the growth occurring at
lower temperatures, and that the SA-dependent growth is competitively inhibited
by p-aminobenzoic acid (PABA).
It was further shown (Zalokar, 1948) that the failure of this strain to grow at
higher temperatures is due to inhibition by the amounts of PABA normally
produced and that the growth-stimulating action of SA results from an antagon-
ism of this inhibition. The sfo mutant was combined with a mutant (1633,
designated "pab") that is unable to synthesize PABA, so that the amount of this
vitamin available to the mycelium could be controlled by adding known amounts
to the medium. The double mutant (sfo, pab) grows maximally on low concen-
trations of PABA and is inhibited strongly by slightly higher concentrations,
which are still 100,000-fold less than are required to inhibit the wild type.
Growth inhibition by the higher concentrations of PABA is competitively
antagonized by SA.
The present paper reports experiments that partially identify the reaction
responsible for the sulfonamide-requiring character. From studies previously
reported it has been supposed that there is a gene-controlled deleterious reaction
(in sfo strains) that requires relatively higher levels of PABA than are needed
for other PABA-dependent metabolic reactions. The present studies show that
the deleterious reaction also requires somewhat more methionine (or homocys-
teine) than the minimum required for normal growth and that the inhibition
resulting from excess methionine is competitively antagonized by threonine
(or homoserine).
NOTE ON METHOD OF PRESENTING DATA
Best results with the sfo character have been obtained by the growth-tube
method (Ryan, Beadle, and Tatum, 1943). Growth tubes 220 mm in length,
1 This investigation was supported by a grant from the American Cancer Society upon
the recommendation of the Committee on Growth of the National Research Council.
2 Present address: Department of Zoology, University of Washington, Seattle, Washing-
ton.
3 The author is grateful to Dr. Sterling Emerson for reading the manuscript and for help-
ful suggestions and criticisms.
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containig 10 ml of 1.5 per cent agar medium were inoculated at one end with
conidia, and the position of the mycelial frontier was recorded at daily intervals.
Growth curves were plotted from such data. Growth curves obtained under
varying conditions differ from one another not only in the final growth rate
but especially in the time required to attain that rate. No single measurement
accurately represents both of these characteristics of the growth curves, but
a fairly good approximation is obtained by using the amount of growth in 3
days, as this is a function of both the length of the lag phase and the rate of
growth thereafter.
With the exception of growth of the double mutant (sfo, me-2) on varying
concentrations of methionine, the entire series of experiments has been repeated
with a freshly isolated ascospore culture of the sfo strain. Both series of experi-
ments agree closely, but only the more recent is summarized in the figures
00mm 00 XP SA
PAS
Figure 1. Action of sulfonamide and some of its antagonists on growth of Neuro-spora.
Growth curves of wild type (E-5256): 00--on min*imal medium; SA, PAB - on 2 X 10-2
sulfanilaide plus 10-16 p-amnobenzoic acid; SA, Me, Ad = on silifanilamide plus lo-a
methionine ancd10-4M adenine isulfate; SA, Me -on sulfanilamide and methionine; SA=
on 2 X 10-2 sulfanilamide.
ROLaE OF METHIONINE IN PABA CONSERVATION AND IN ILN BITION BY SA
It has been shown that PABA deficiency in bacteria, whether a result of muta-
tion or of SA inhibition, can be relieved by supplementing the mediulm with
several unrelated substances (cf. Kohn, 1943). Methionine suppresses the greater
part of SA inhibition (Harris and Kohn, 1941, a, b; Lampen, Roepke, and Jones,
1946). Purines, when added with methionine, alleviate inhibition by SA even
more (Harris and Kohn, 1941 a,b; Shive and Ro'berts, 1946). In some bacteria,
thymine can replace the requirement for folic acid, a derivative of PABA (Snell
and Mitchell, 1941; Stokes, 1944). In a recent paper Strehler (1950) describes
a mutant of Neuros-pora that requires either PABA or methionine for growth. Our
results, reported here, are consistent with his observations.
The inhibition of wild type Neurospora by SA is partially coulnteracted by
methionine (figure 1). The further addition of adenine or guanine results in a
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SULFONAMIDE-REQUIRING MUTANT OF NEUROSPORA
still greater reduction in the inhibition caused by SA, but these supplements
never completely overcome the effect of SA. Similarly, when grown on sub-
optimal amounts of PABA, the pab strain responds much better if methionine
and adenine (or guanine) are added to the medium (figure 2), but these sub-
stances do not completely substitute for PABA. Thymine is without effect in
this relationship.
METHIONINE AS INHIBITOR OF SFO STRAIN
The sfo mutant, on the other hand, is slightly inhibited by methionine even
in the presence of SA. As in the earlier studies in which the double mutant
(sfo, pab) was used in showing a PABA requirement of the sfo strain (Zalokar,
1948), it is possible in this case to study the effect of methionine on the sfo
character by introducing into the sfo strain mutant genes that block the synthesis
of methionine. In this instance the responses of double mutants (carrying sfo
00mm
PABg
150 /^Ad
100
Ad
20 40 60 80 100 120 140 160 180 h
Figure 2. Growth curves of p-aminobenzoic-acid-less strain of Neurospora (1833): PAB
-on l0-si p-aminobensoic acid; Me, Ad = on 10sm methionine and 10'i adenine sulfate;
Me = on methionine alone; Ad - on adenine sulfate alone; 00 - on minimal medium.
and a genetic block to methionine synthesis) differed depending upon the par-
ticular step in the synthesis that was blocked (see suemmary in table 1).
The steps through which the biosynthesis of methionine takes place in Neuro-
spora have been worked out by Horowitz (1947a,b), and mutant strains that
block each step are known (figure 3). Mutant 39816 is blocked before the syn-
thesis of cysteine (step me4); it will grow if supplied with cysteine or any product
appearing later in the reactions leading to methionine. Strains 9666, 36104,
and 39103 (which are genetically distinct; Buss, 1944) block the synthesis of
cystathionine (step me-3); their growth is not supported by cysteine, but they
do grow if supplied cystathionine or any later product. Mutant H-98 cannot
split cystathionine to give homocysteine (me-2) and accumulates cystathionine
in the medium; its growth is supported by either homocysteine or methionine,
but not by products earlier in the series. Finally strains 32213, 35809, 37603,
38706, 44704, 47806, and 48003 are unable to methylate homocysteine to pro-
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SULFONAMIDE-REQUIRING MUTANT OF NEUROSPORA
duce methionine (me-i); these have specific requirements for methionine, with
the exception of 37603, which requires either methionine or choline (the genetic
relationships of these strains are not completely known).
Double mutants (sfo, me-3 and sfo, me-2), in which the block to methionine
synthesis precedes homocysteine, show increased growth with increasing DL-
methionine concentration up to about 2 X 10-5M (3 jig per ml). Higher con-
centrations of methionine are inhibitory (figure 4). The growth of the double
mutants at any given concentration is always less than that of the corresponding
simple methionineless mutant.
Sulfanilamide antagonizes the inhibition of the double mutants in a noncom-
petitive manner. In the presence of enough SA to permit growth of the sfo
strain, the double mutants (sfo, me) respond to increased methionine concentra-
300mm H-98
200
MET/IONINE 00 PAB M
, 10|-s , 10lo0-413M
Figure 4. Growth rates expressed as mm grown in 72 hours of the double mutant, sul-
fonamide-requiring, methionineless (sfo, me-2) on varying concentrations of methionine
00, PAB = identical curves on minimal medium with or without addition of 104M p-amino-
benzoic acid; SA = growth on minimal medium supplemented with 104M sulfanilamide;
H-98 =growth of simple me-2 mutant.
tion as the simple methionineless mutants, except for the slight inhibition at
high concentrations characteristic of the simple sfo strain (figure 4).
When the double mutant (sfo, me) is grown on the concentration of methi-
onine permitting greatest growth (about 2 X 10-5M), added PABA is without
effect as a growth inhibitor (figure 4).
Homocysteine, the precursor of methionine, has an inhibitory action similar
to, but less pronounced than, that of methionine. In practice, homocysteine
was added to the medium in the more stable form of its thiolactone hydro-
chloride,4 which has to be reconverted in the organism to homocysteine. As the
thiolactone, homocysteine has been found to be less effective than methionine
in supporting growth of mutants blocked before homocysteine (Horowitz, 1947b).
It is therefore not surprising that it is also less effective in inhibiting growth of
the sfo strains.
4 I am indebted to Dr. Marguerite Fling who kindly supplied me with homocysteine thio-
lactone hydrochloride that she had synthesized.
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The behavior of mutant strains blocked between homocysteine and methionine
(step me-i) is not completely self-consistent (table 1). Double mutants derived
from crosses between sfo and strains 38706, 44704, and 47806 all behave in the
same way. They do not grow at any concentration of methionine whatsoever.
In the presence of SA these double mutants respond to methionine exactly like
the simple methionineless strains.
Mutant 37603, which can grow on either methionine or choline but not on
homocysteine, differs from other mutants that can utilize methionine but not
homocysteine. When this mutant gene is combined with sfo, the resulting double
mutant responds differently depending upon whether choline or methionine
is supplied to the medium. With increasing methionine concentration growth
rises to a peak at 2 X 10-i M, above which inhibition sets in. In this respect
TABLE 1
Growth of different sulfonamide-requiring, methionineless double mutants on methionine
DOUBLE MUTANT MTON ADDID
Mcthioninele 0 2 X 10x10a 10-' SA 10st@eo
sfo, me-1 38706 _ - - ++ ++
44704 _ - - ++ ++
47806 _ - - ++ ++
sfo, me-1 37603 - + - +
sfo, me-i 32213 - =i* ++ +
35809 - +* ++
48003 - +* ++
sfo, me-2 H-98 - + ++ ++
sfo, me-3 36104 - + ++ ++
* Initial growth, but stopping after a short interval.
the mutant resembles those that are blocked before homocysteine rather than
after. When choline is used to support growth, on the other hand, growth of the
double mutant increases with increasing concentration, with no inhibition
resulting from excess choline.
Another group of mutants (32213, 35809, and 48003) that also utilize methi-
onine but not homocysteine have given still different results. Double mutants
in which these mutants are combined with sfo make an initial growth when
methionine alone is supplied to the medium, and the higher the methionine
concentration, the greater the initial growth rate, but growth is not maintained
on any concentration of methionine.
There is other evidence indicating that mutant strains that utilize methionine
but not homocysteine do not constitute a hombgeneous group. They can be
separated into three groups on the basis of their ability to reduce selenite under
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SULFONAMIDE-REQUIRING MUTANT OF NEUROSPORA
different conditions (Zalokar, 1950), and there is recent evidence that members
of the three groups so defined are genetically distinct (M. Fling, personal com-
munication). Those mutants which, when combined with sfo, do not grow on
methionine belong to the group that reduces selenite only in the presence of
methionine. Those which as double mutants produce some growth on methionine
belong to the group that fails to reduce selenite under any condition. The third
group contains mutants that are always able to reduce selenite.
THEONINE ANTAGONISM OF METHIONINE IENIBITION
In the search for methods of identifying the reaction involved in the inhibition
of the sfo strain by methionine a number of postulates were considered. One of
these presupposed that homocysteine (the precursor of methionine and perhaps
the real inhibitor) might combine with homoserine to give a thioether (homo-
00mm~~ ~ ~~~~0
100/,
ME7T/OMNE
.10r5 . .OrF4 . . 1°0r3M
Figure 5. Growth rates of the double mutant (sfo, me-2) on different concentrations of
methionine:OO - minimal medium with 10-z threonine; PAB = minimal medium with
threonine and 10-'m p-aminobenzoic acid.
lanthionine; Stekol, 1948) resembling cystathionine, which is similarly formed
from cysteine and homoserine (cf. Binkley and Du Vigneaud, 1942). One result
of such a reaction might be a deficiency of homoserine for other essential reac-
tions, and since threonine is derived from homoserine (Teas, Horowitz, and
Fling, 1948), a deficiency for threonine might result. No direct evidence for the
production of the postulated thioether has been obtained, but the sfo strain
does respond as if it had a deficiency of threonine or homoserine.
Either homoserine or threonine can support growth of the sfo strain at 35 C
in the complete absence of SA. At concentrations of 60 utg per ml or more of
either growth of the sfo strain equals that of the wild type. Furthermore, at
relatively high concentrations of threonine, PABA has no inhibitory effect
(figure 5).
In the double mutants (sfo, me-2 and sfo, me-3), in which the available
methionine can be controlled, there is a competitive antagonism between thre-
onine and methionine. Methionine inhibition is reduced about 50 per cent by
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equimolar proportions of threonine and is completely overcome at molar con-
centrations two or three times greater than that of methionine (figure 6). At
high concentrations of both substances, threonine is relatively more efficient
as an antagonist to methionine.
The antagonistic action of threonine and homoserine toward methionine
is fairly specific. Many other amino acids were tested by two methods. In one
Figure 6. Growth rates of the double mutant (sfo, me-2) on varying concentrations of
methionine and threonine.
00 mm
150 e i
100~~~~~~~~~~~0.
20 40 60 80 loo 120 140 h
Figure 7. Growth curves of a sulfonamide-requiring strain on different amino acids,
added in 10sm to the medium. Curve of wild type and of sfo type on 1O-4M sulfonamide (8a)
and on minimal medium (00) for comparison.
procedure, the amino acids were tested (at 10-i M concentrations) for a threonine-
like stimulation of the sfo mutant. In the other, tests were made with the double
mutant (sfo, me-2) in the presence of 2 X 10-4M threonine and 2 X 10 4M methi-
onine, a mixture resulting in about 50 per cent inhibition of growth. In this
situation, if the test substance (again added at 10-3 M) was antagonistic to methi-
onine, growth stimulation should result; if it was indifferent there should be no
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SULFONAMIDE-REQUIRING MUTANT OF NEUROSPORA
change; and if the substance itself was inhibitory there should be reduced growth.
The following substances proved to be indifferent by both tests: DL-alanine,
L-arginine, DL-citrulline, L-cystine, L-glutamiC acid, glycine, L-histidifne, L-leucine,
L-lysine, DL-norleucine, DL-ornithine, L-proline, DL-serine, L-tryptophan, and L-
tyrosine.
Figure 8. Growth curves of double mutant, sfo, me-2, on different amino acids. All media
except the threonine control were supplemented with 2 X 10-4M methionine and 2 X 1O-4
threonine; other amino acids indicated were added in 10M3m concentration.
100
ISO0~~~~~~~
20 40 60 80 100 120 140 h
Figure 9. Growth curves of a sulfonamide-requiring strain on pH-raising substances and
two C4-chain growth-promoting substances.
A paradoxical behavior was found in tests with DL-isoleucine, DL-valine, and,
in lesser degree, a-aminobutyric acid and asparagine. They each stimulate
growth of the sfo strain (figure 7). They each reduce the inhibition of the sfo
me-2 double mutant resulting from 30 ,ug per ml of methionine. In the presence
of equal amounts of threonine and methionine, however, these substances are
rather inhibitory (figure 8). No substance tested (except SA) is equal to threonine
or homoserine in stimulatory action, nor to methionine as an inhibitor.
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A common characteristic of all amino acids that either inhibit or antagonize
the inhibition of the sfo mutant is a 4-carbon chain. Some other C4 substances
were tested. Acetoacetic, fumaric, malic, and succinic acids are without activity.
Crotonic acid is inhibitory, but it is also inhibitory to the wild type. Of the
substances tested, a-ketobutyric acid and ,8-methyl crotonic acid (synthesized
by Dr. B. Arreguin-Lozano) have a very obvious stimulatory action. The growth
of the sfo strain promoted by those substances, however, was not equal to that
promoted by threonine (figure 9). ,8-Methyl crotonic acid is inhibitory to both the
wild type and the mutant. A one-thousandth molar solution distinctly inhibits
the wild type, reducing the growth to less than half. One quarter of this amount
is still inhibitory to the wild type, but at the same time stimulatory for the
mutant.
EFFECT OF HYDROGEN ION CONCENTRATION
The expression of the sfo character was found to depend on hydrogen ion
concentration. The sfo strain fails to grow on minimal medium at 35 C in the
range pH 4 to pH 6, which is generally realized in the culture medium. If the
medium is kept about pH 7 by addition of CaCO3, growth of the mutant is
nearly normal (figure 9). A high pH can also be obtained by the addition of urea
to the medium. Urea is decomposed by mold enzymes and ammonia liberated,
keeping the pH .high. Urea supports very good growth of the sfo strain in the
absence of sulfanilamide or threonine. In this case, however, the response may
be due to free ammonia as well as to high pH.
A medium containing no ammonia, one in which all nitrogen is in the form of
nitrate, does not stimulate growth of the sfo strain even at high pH. It may be
that the only effect of high pH is to keep free ammonia in the medium and make
it available to the organism.
DISCUSSION
The reported results show that methionine or its precursor inhibits threonine
utilization under the influence of the sfo gene, thus inhibiting growth. A similar
inhibition was reported by Teas, Horowitz, and Fling (1948) in the homoserine-
less mutant 51504. This mutant requires homoserine, or both threonine and
methionine for growth, but too much methionine inhibits growth in competition
with threonine. This inhibition cannot be of the same nature as that reported
here. It is not influenced by temperature and sulfanilamide cannot antagonize
it. By contrast, a-aminobutyric acid and isoleucine are better antagonists than
they are in our case. Only L-methionine inhibits the mutant 51504; D-methionine
is without action, although it can support growth of methionine-deficient
mutants. Tests of the inhibitory action of both methionine isomers on the sfo
mutant show that both inhibit but that L-methionine is several times as active
as D-methionime, DL-methionine being intermediate in effect.
The failure of the sfo strain to grow on unsupplemented media can best be
accounted for by the supposition that there is a reaction in this strain that is
catalyzed by PABA, that uses methionine (or homocysteine) as substrate, and
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SULFONAMIDE-REQUIRING MUTANT OF NEUROSPORA2
that leads to a deficiency of threonine (or homoserine). Homocysteine shows
some of the inhibitory action characteristic of methionine. Mutants blocked
after homocysteine but before methionine are able to produce the first sub-
stance (and possibly accumulate it) but not the second substance. Double mu-
tants between certain of these and the sfo mutant (sfo, me-l) behave as though
they are completely inhibited by methionine no matter how little methionine is
added to the medium (cf. table 1). In such double mutants the inhibition must
be caused by a precursor of methionine. The precursor of methionine that is
directly involved is not necessarily homocysteine. There must be two or three
"steps" to the methylation of homocysteine, since the over-all reaction is blocked
by at least three genetically independent mutations which differ from one another
in relation to methionine inhibition of the sfo character and selenite reduction.
The steps controlled by the particular mutants under discussion are not known.
Since methionine is the best inhibitor although the evidence just mentioned
suggests its precursor as inhibitor, it must be supposed that methionine is readily
converted into that precursor. In animal experiments there is evidence that
methionine can give up the methyl group and be converted to homocysteine
(cf. Du Vigneaud 1942-1943; Virtue and Lewis, 1934; Brand, Cahill, and
Block, 1935). There is no direct proof of a similar reaction in Neurospora. In-
directly, the supposition finds support in the observation that methionine can
substitute for cysteine.
Methionine could be transformed to cysteine either in the reverse of the path-
way of synthesis (figure 3) or by some other route resulting in a cyclic reaction.
The second supposition is more likely since methionine can be used as a cysteine
substituent even when the synthetic steps between the latter and the former
are blocked by mutation. A double mutant, cysteineless (39816) and methionine-
less (H-98), should require both cysteine and methionine for growth if methi-
onine could not be converted into cysteine. Actually growth is supported by the
addition of methionine alone. Simir results have been obtained by S. C. Shen
(unpublished) using double mutants between cysteineless (36106) and methi-
onineless (29627 and 44704) strains in which the block is between homocysteine
and methionine. Both double mutants utilize methionine as the sole source of
sulfur.
Since both threonine and homoserine are completely effective in overcoming
the inhibition caused by methionine (or homocysteine) in the sfo strain, and
since such diverse substances as valine, isoleucine, ,8-methyl crotonic acid, urea,
and ammonia at high pH are all partially effective, it is difficult to guess the
nature of the normal process that is interfered with in this inhibition. On the
other hand, homoserine has been shown to be a precursor of both threonine and
methionine (Teas, Horowitz, and Fling, 1948), isoleucine can partially substitute
for threonine in one of the threonineless mutants (Teas, 1948), and isoleucine
and valine are closely interrelated (Bonner, 1946). It may be that one of the
normally occurring interactions between these substances is the one that is in-
hibited by methionine in the sfo strain. Beta-methyl crotonic acid may owe its
effectiveness to its structural similarity to valine or to some intermediate in
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2MARKOZALOK[AR
threonine synthesis. The effectiveness of urea and of ammonia at high pH sug-
gests that the inhibited reaction may be one involving amination. Since the
antagonistic reactions discussed are competitive, it would seem that inhibition
by methionine must involve a reaction in which threonine is utilized; a precursor
of threonine could be utilized directly in the inhibited reaction only if the steps
between the precursor and threonine were reversible.
SUMMARY
If the synthesis of p-aminobenzoic acid (PABA) by the sulfonamide-requiring
(sfo) strain of Neurospora is prevented by the introduction of a genetic block
(Zalokar, 1948), growth is supported by low concentrations of PABA but is in-
hibited by higher concentrations. Inhibition by PABA is competitively antago-
nized by sulfanilamide (SA).
Experiments are reported which show that if the synthesis of methionine by
the sfo strain is similarly prevented by the introduction of a genetic block pre-
ceding the synthesis of homocysteine, growth is supported bylow concentrations
(2 X 10- M) of methionine (or homocysteine) but is inhibited by higher con-
centrations. Inhibition by methionine is competitively antagonized by threonine
(or homoserine).
Four antagonistic reactions have now been observed in the sfo strain. The
inhibition of growth by excess PABA is competitively antagonized by SA and
noncompetitively by threonine. Inhibition by excess methionine is competitively
antagonized by threonine and noncompetitively by SA.
Five methods are now known by which growth of the sfo strain can be sup-
ported. These are (1) by the addition of SA, (2) by reducing available PABA
by genetic means, (3) by reducing available methionine by genetic means, (4)
by the addition of threonine, and (5) by making free ammonia available.
The present interpretation of these results is that the sfo gene controls a
deleterious reaction with the following characteristics: (1) it requires a precursor
of methionine as substrate, and the amount required is greater than that needed
for essential reactions normally using the same substrate; (2) it requires PABA
as a catalyst, and in much larger amounts than are required by other reactions
using the same catalyst; (3) at the same time SA is a much stronger competitor
of PABA in this reaction than in other reactions requiring PABA as catalyst;
and (4) the reaction, or a product of the deleterious reaction, interferes with
the normal utilization of threonine. That the step in threonine utilization inter-
fered with may involve amination is suggested by the growth-promoting activity
of free ammonia.
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